N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide

C37H35F6N9O4 — CID 176641311

IUPACN-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide
SMILESO=C1CCC(n2c(=O)[nH]c3c([C@H]4CCN(CC5CCC(n6cc7cc(NC(=O)c8cncc(C(F)(F)F)n8)ccc7n6)CC5)CC4(F)F)c(F)ccc32)C(=O)N1
InChIInChI=1S/C37H35F6N9O4/c38-24-6-8-27-32(48-35(56)52(27)28-9-10-30(53)47-34(28)55)31(24)23-11-12-50(18-36(23,39)40)16-19-1-4-22(5-2-19)51-17-20-13-21(3-7-25(20)49-51)45-33(54)26-14-44-15-29(46-26)37(41,42)43/h3,6-8,13-15,17,19,22-23,28H,1-2,4-5,9-12,16,18H2,(H,45,54)(H,48,56)(H,47,53,55)/t19?,22?,23-,28?/m1/s1
InChIKeyAAAMXOAYNAHXSH-RTSTWSDNSA-N
MW783.73 g/mol
LogP5.71
Rot. Bonds7

About N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide

N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide (PubChem CID 176641311) has the molecular formula C37H35F6N9O4 and a molecular weight of 783.73 g/mol. Its IUPAC name is N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide
PubChem CID176641311
Molecular FormulaC37H35F6N9O4
Molecular Weight783.73 g/mol
Exact Mass783.27
IUPAC NameN-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide
SMILESO=C1CCC(n2c(=O)[nH]c3c([C@H]4CCN(CC5CCC(n6cc7cc(NC(=O)c8cncc(C(F)(F)F)n8)ccc7n6)CC5)CC4(F)F)c(F)ccc32)C(=O)N1
InChIInChI=1S/C37H35F6N9O4/c38-24-6-8-27-32(48-35(56)52(27)28-9-10-30(53)47-34(28)55)31(24)23-11-12-50(18-36(23,39)40)16-19-1-4-22(5-2-19)51-17-20-13-21(3-7-25(20)49-51)45-33(54)26-14-44-15-29(46-26)37(41,42)43/h3,6-8,13-15,17,19,22-23,28H,1-2,4-5,9-12,16,18H2,(H,45,54)(H,48,56)(H,47,53,55)/t19?,22?,23-,28?/m1/s1
InChIKeyAAAMXOAYNAHXSH-RTSTWSDNSA-N
XLogP5.71
TPSA159.90 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms56
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500783.73
LogP ≤ 55.71
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
The IUPAC name of N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide (CID 176641311) is N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide.
What is the SMILES notation for N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
The canonical SMILES for N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide is O=C1CCC(n2c(=O)[nH]c3c([C@H]4CCN(CC5CCC(n6cc7cc(NC(=O)c8cncc(C(F)(F)F)n8)ccc7n6)CC5)CC4(F)F)c(F)ccc32)C(=O)N1.
What is the InChIKey of N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
The InChIKey is AAAMXOAYNAHXSH-RTSTWSDNSA-N. The full InChI is InChI=1S/C37H35F6N9O4/c38-24-6-8-27-32(48-35(56)52(27)28-9-10-30(53)47-34(28)55)31(24)23-11-12-50(18-36(23,39)40)16-19-1-4-22(5-2-19)51-17-20-13-21(3-7-25(20)49-51)45-33(54)26-14-44-15-29(46-26)37(41,42)43/h3,6-8,13-15,17,19,22-23,28H,1-2,4-5,9-12,16,18H2,(H,45,54)(H,48,56)(H,47,53,55)/t19?,22?,23-,28?/m1/s1.
What are the key properties of N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide has a molecular weight of 783.73 g/mol, XLogP of 5.71, 7 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[(4R)-4-[1-(2,6-dioxopiperidin-3-yl)-5-fluoro-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide is sourced from PubChem (CID 176641311), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).